Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Launched by CHIREC · Jan 20, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the use of artificial intelligence (AI) to help doctors during colonoscopies, which are tests that look inside the colon to find and remove small growths called polyps. Some of these polyps, particularly adenomas, can turn into cancer over time. The goal of the study is to see if using AI during these procedures can help doctors find and remove more polyps compared to regular colonoscopies, potentially reducing the risk of colon cancer.

To participate in this trial, you need to be between the ages of 45 and 74 and eligible for a screening colonoscopy, which means you don't have any serious digestive issues that require the test for other reasons. If you join the study, you will undergo a colonoscopy, and researchers will compare how many polyps are found with and without the help of AI. This research is important because it could lead to better detection and prevention of colon cancer in the future.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Patient (woman or man) candidate for a screening colonoscopy - Age: 45 to 74 years included
• • Absence of inflammatory bowel disease
• • Absence of significant digestive symptoms indicating colonoscopy (i.e. screening is the only indication for the examination)
• • Patient able to understand the concept of the study and agreeing to participate
• Exclusion criteria:
• • Patient outside the inclusion age
• • All exclusion criteria for a colonoscopy.
• • The indication for colonoscopy is not simple screening; for example, assessment of anemia, rectal bleeding, weight loss or abdominal pain.
• • Patient's refusal to participate, or patient's inability to understand the study concept
• • Any patient with major psychological or psychiatric disorders.